These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15302729)

  • 1. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis.
    Nadrous HF; Ryu JH; Douglas WW; Decker PA; Olson EJ
    Chest; 2004 Aug; 126(2):438-46. PubMed ID: 15302729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin blockers/inhibitors and statins on mortality and functional impairment in polypathological patients.
    Galindo-Ocaña J; Bernabeu-Wittel M; Formiga F; Fuertes-Martín A; Barón-Franco B; Murcia-Zaragoza JM; Moreno-Gaviño L; Ollero-Baturone M;
    Eur J Intern Med; 2012 Mar; 23(2):179-84. PubMed ID: 22284251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and antacid treatment and mortality in oxygen-dependent pulmonary fibrosis: A population-based longitudinal study.
    Ekström M; Bornefalk-Hermansson A
    Respirology; 2016 May; 21(4):705-11. PubMed ID: 27009834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies.
    Wedlake LJ; Silia F; Benton B; Lalji A; Thomas K; Dearnaley DP; Blake P; Tait D; Khoo VS; Andreyev HJ
    Eur J Cancer; 2012 Sep; 48(14):2117-24. PubMed ID: 22386574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis.
    Kreuter M; Lederer DJ; Molina-Molina M; Noth I; Valenzuela C; Frankenstein L; Weycker D; Atwood M; Kirchgaessler KU; Cottin V
    Chest; 2019 Oct; 156(4):706-714. PubMed ID: 31047956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis.
    Rosenhek R; Rader F; Loho N; Gabriel H; Heger M; Klaar U; Schemper M; Binder T; Maurer G; Baumgartner H
    Circulation; 2004 Sep; 110(10):1291-5. PubMed ID: 15337704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-life use of the polypill components (ASA+ACEI+statins) after an acute coronary syndrome and long-term mortality.
    Oliveras Vilà T; Ferrer Massot M; Curós Abadal A; Rueda Sobella F; Serra Flores J; Carrillo Suárez X; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):209-10. PubMed ID: 25499380
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic.
    Stiles KP; Abbott KC; Welch PG; Yuan CM
    Clin Nephrol; 2001 Aug; 56(2):89-95. PubMed ID: 11522100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery.
    Ouzounian M; Buth KJ; Valeeva L; Morton CC; Hassan A; Ali IS
    Ann Thorac Surg; 2012 Feb; 93(2):559-64. PubMed ID: 22269723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk.
    Kumar S; Savitz S; Schlaug G; Caplan L; Selim M
    Neurology; 2006 Apr; 66(8):1153-8; discussion 1135. PubMed ID: 16636230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
    Happold C; Gorlia T; Nabors LB; Erridge SC; Reardon DA; Hicking C; Picard M; Stupp R; Weller M;
    J Neurooncol; 2018 May; 138(1):163-171. PubMed ID: 29423540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the Risk of Drug-Induced Pancreatitis With Angiotensin-Converting Enzyme Inhibitors and Statins Using a Large Electronic Medical Record Database.
    Twohig PA; de-Madaria E; Thakkar S; Dulai P; Gardner TB; Kochhar G; Sandhu DS
    Pancreas; 2021 Sep; 50(8):1212-1217. PubMed ID: 34714286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor in peritoneal dialysis patients.
    Jovanović N; Božinovski SŽ; Krstić S; Obrenović R; Trbojević-Stanković J; Stojimirović B
    Clin Lab; 2014; 60(10):1695-701. PubMed ID: 25651716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.